|
| 1 |
Factors Associated With Neurocognitive Impairment Following Chemoradiotherapy in Patients With High-Grade Glioma: Results of a Prospective Trial
Prashasti Sharma, Partha Pratim Medhi, Apurba Kumar Kalita, Mouchumee Bhattacharyya, Jyotiman Nath, Gautam Sarma, Yanpothung Yanthan
|
|
| 2 |
Mutant IDH1 Enhances Temozolomide Sensitivity via Regulation of the ATM/CHK2 Pathway in Glioma
Lin Lin, Jinquan Cai, Zixiao Tan, Xiangqi Meng, Ruiyan Li, Yang Li, Chuanlu Jiang
Cancer Res Treat.2021;53(2):367-377. Published online 2020 October 13
DOI: http://dx.doi.org/10.4143/crt.2020.506
|
|
| 3 |
Reclassification of Mongolian Diffuse Gliomas According to the Revised 2016 World Health Organization Central Nervous System Tumor Classification
Enkhee Ochirjav, Bayarmaa Enkhbat, Tuul Baldandorj, Gheeyoung Choe
|
|
| 4 |
A Survey of the Neuro-Oncology Landscape
Rimas V. Lukas, Jing Wu, Mahua Dey, Robin A. Buerki, Richard W. Byrne, George J. Dohrmann
J Clin Neurol.2018;14(1):8-15. Published online 2017 October 31
DOI: http://dx.doi.org/10.3988/jcn.2018.14.1.8
|
|
| 5 |
In-Vivo Proton Magnetic Resonance Spectroscopy of 2-Hydroxyglutarate in Isocitrate Dehydrogenase-Mutated Gliomas: A Technical Review for Neuroradiologists
Hyeonjin Kim, Sungjin Kim, Hyeong Hun Lee, Hwon Heo
|
|
| 6 |
Immunohistochemical Analysis of ATRX, IDH1 and p53 in Glioblastoma and Their Correlations with Patient Survival
Ajay Chaurasia, Sung-Hye Park, Jeong-Wook Seo, Chul-Kee Park
|
|
| 7 |
Malignant Glioma with Neuronal Marker Expression : A Clinicopathological Study of 18 Cases
Hong Rye Kim, Jae Jun Lee, Jung-Il Lee, Do Hyun Nam, Yeon-Lim Suh, Ho Jun Seol
|
|
| 8 |
Application of Volumetric Analysis to Glioblastomas: a Correlation Study on the Status of the Isocitrate Dehydrogenase Mutation
Seon Yong Bae, Chul-Kee Park, Tae Min Kim, Sung-Hye Park, Il Han Kim, Seung Hong Choi
|
|
| 9 |
IDH Mutation Analysis in Ewing Sarcoma Family Tumors
Ki Yong Na, Byeong-Joo Noh, Ji-Youn Sung, Youn Wha Kim, Eduardo Santini Araujo, Yong-Koo Park
|
|
